NASDAQ
Mereo BioPharma Group plc - American Depositary Shares (MREO)
♥ 570 Thanks from members
Mereo BioPharma Group plc (MREO) faces a split market narrative: while advancing rare disease pipelines like setrusumab and alvelestat with partners, the stock battles severe downward pressure, a negative Wall Street consensus, and a NASDAQ delisting warning due to its sub-$1.00 price.